Biomarin Pharmaceutical Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
&; -
Hey, guys. I'm Ellie Merle. I'm one of the biotech analysts here at Cantor. Very happy to have BioMarin here with us today at the Cantor conference. Guys, thanks so much for joining us here. With us from BioMarin is Hank Fuchs, President, Worldwide R&D; as well as Brian Mueller, Executive Vice President, Chief Financial Officer. Thanks so much for joining us today.
Questions & Answers
&; -
Maybe before I dive into questions, maybe, Brian, can you frame for us, not starting with Valrox, where we are with the base business and your confidence in sort of the sustainability and long-run sort of cash generation from this business?
Yes. Thanks, Ellie. Thanks for having us, and thanks for the question. So that's one of the key, I think, considerations, especially
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |